文献速递血栓与止血

儿童和青少年COVID-19或MIS-C住院患者血栓发生率

Rate of thrombosis in children and adolescents hospitalized with COVID-19 or MIS-C.
PubMed 文献 · Blood · 2021-01-01

这项多中心回顾性队列研究分析了814例患者共853次因COVID-19、MIS-C或无症状SARS-CoV-2感染的住院,评估血栓事件发生率及相关危险因素。MIS-C患者血栓发生率最高(6.5%),≥12岁MIS-C患者达19%。多变量分析显示年龄≥12岁、癌症、中心静脉导管和MIS-C与血栓显著相关。

要点

  • MIS-C住院患儿血栓发生率6.5%,高于COVID-19的2.1%和无症状感染的0.7%。
  • ≥12岁MIS-C患者血栓发生率最高达19%。
  • 71%非入院时存在的血栓事件发生在血栓预防措施下。

核心结论

  • 儿童和青少年COVID-19或MIS-C住院患者中,MIS-C及≥12岁者血栓风险最高,血栓与住院死亡相关。

研究设计与样本

  • 多中心回顾性队列研究,共814例患者853次住院,分为COVID-19组426例、MIS-C组138例、无症状SARS-CoV-2组289例。

主要发现

  • 共20例血栓事件(含1例卒中),MIS-C组9/138(6.5%),COVID-19组9/426(2.1%),无症状组2/289(0.7%)。
  • COVID-19或MIS-C患者中89%血栓事件发生于年龄≥12岁者,≥12岁MIS-C患者血栓率19%(9/48)。
  • 71%非入院时存在的血栓事件发生在血栓预防措施下。
  • 多变量分析显示年龄≥12岁、癌症、中心静脉导管和MIS-C与血栓显著相关。
  • COVID-19或MIS-C患者住院死亡率为2.3%(13/564),血栓事件患者死亡率为28%(5/18)。

临床怎么用

  • 对≥12岁MIS-C住院患者应加强血栓风险评估与预防策略的个体化考量。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is associated with thrombotic complications in adults, but the incidence of COVID-19-related thrombosis in children and adolescents is unclear. Most children with acute COVID-19 have mild disease, but coagulopathy has been associated with multisystem inflammatory syndrome in children (MIS-C), a postinfectious complication. We conducted a multicenter retrospective cohort study to determine the incidence of thrombosis in children hospitalized with COVID-19 or MIS-C and evaluate associated risk factors. We classified patients into 1 of 3 groups for analysis: COVID-19, MIS-C, or asymptomatic SARS-CoV-2. Among a total of 853 admissions (COVID-19, n = 426; MIS-C, n = 138; and asymptomatic SARS-CoV-2, n = 289) in 814 patients, there were 20 patients with thrombotic events (TEs; including 1 stroke). Patients with MIS-C had the highest incidence (9 [6.5%] of 138) vs COVID-19 (9 [2.1%] of 426) or asymptomatic SARS-CoV-2 (2 [0.7%] of 289). In patients with COVID-19 or MIS-C, a majority of TEs (89%) occurred in patients age ≥12 years. Patients age ≥12 years with MIS-C had the highest rate of thrombosis at 19% (9 of 48). Notably, 71% of TEs that were not present on admission occurred despite thromboprophylaxis. Multivariable analysis identified the following as significantly associated with thrombosis: age ≥12 years, cancer, presence of a central venous catheter, and MIS-C. In patients with COVID-19 or MIS-C, hospital mortality was 2.3% (13 of 564), but it was 28% (5 of 18) in patients with TEs. Our findings may help inform pediatric thromboprophylaxis strategies.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Whitworth H, Sartain SE, Kumar R, et al. Rate of thrombosis in children and adolescents hospitalized with COVID-19 or MIS-C. Blood. 2021. PMID: 33895804. doi:10.1182/blood.2020010218

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。